Stem Cells for Drug Discovery

Knowledge Source Identification
Knowledge source name Stem Cells for Drug Discovery
Abbreviated name StemBANCC
Owner/Developer Innovative Medicines Initiative
Abbreviated owner IMI
Country Switzerland
Languages English
Description StemBANCC is a large-scale, 5 year academic-industry partnership in the area of stem cell research. It brings a consortium of 35 partners together who share their experience and collaborate in 12 work packages. It is a collaborative project between pharmaceutical companies, research institutions and small and medium enterprises (SMEs) to exploit the rich expertise across sectors and enhance knowledge transfer between academia and industry for patient benefit. StemBANCC aims to provide well characterised patient derived induced pluripotent stem cell lines and associated biomaterials in an accessible and sustainable bio-bank. StemBANCC also aims to demonstrate proof of concept for the utility of induced pluripotent stem cells in drug discovery for hard-to-treat disorders.
Knowledge Source Category
Category Research Program/Project/Grant
Sub categories EU Program
Knowledge Dissemination and Sharing
Dissemination channel Website
Targeted audience (specified/objective analysis) Researchers
Users access Open access
Knowledge Characterization
3Rs relevance Replacement, Reduction
Purpose Method development
Technology/Tools Alternative test methods (in vitro), Stem cells